Work

Host-influenza proteomics leads to metabolic drug repurposing that reduces viral burden while significantly improving survival after lethal infection (TECH2P.917)

Year: 2015

Type: conference-abstract

Source: The Journal of Immunology

DOI: 10.4049/jimmunol.194.supp.206.27

Authors: Heather Smallwood, Marie Morfouace, Susu Duan, Ruoning Wang, Erika Zink, Barry Shulkin, Douglas Green, Ljiljana Pasa-Tolic, Paul Thomas

Institutions: St. Jude Children's Research Hospital, The Ohio State University, Pacific Northwest National Laboratory

Language: English

Topic: Influenza Virus Research Studies

Subfield: Epidemiology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2772054289

Cites:

Cited by:

Related to: 10